Bogart Wealth LLC’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.92K Buy
49
+13
+36% +$1.07K ﹤0.01% 1126
2025
Q4
$3.07K Buy
36
+14
+64% +$1.15K ﹤0.01% 1101
2025
Q3
$1.71K Sell
22
-7
-24% -$547 ﹤0.01% 1188
2025
Q2
$2.27K Sell
29
-1,011
-97% -$75.4K ﹤0.01% 1083
2025
Q1
$75.4K Sell
1,040
-91,728
-99% -$6.57M ﹤0.01% 339
2024
Q4
$6.87M Buy
92,768
+25,657
+38% +$1.8M 0.33% 73
2024
Q3
$4.43M Buy
67,111
+5,408
+9% +$393K 0.21% 94
2024
Q2
$5.7M Buy
+61,703
New +$5.46M 0.29% 84
2023
Q4
Sell
-23
Closed -$1.59K 1084
2023
Q3
$1.59K Hold
23
﹤0.01% 909
2023
Q2
$2.17K Sell
23
-48
-68% -$4.17K ﹤0.01% 868
2023
Q1
$5.87K Sell
71
-239
-77% -$18.8K ﹤0.01% 682
2022
Q4
$23.1K Buy
310
+10
+3% +$771 ﹤0.01% 411
2022
Q3
$25K Buy
+300
New +$28.9K ﹤0.01% 398
2022
Q2
Sell
-2,136
Closed -$251K 907
2022
Q1
$251K Hold
2,136
0.02% 147
2021
Q4
$277K Hold
2,136
0.03% 143
2021
Q3
$242K Hold
2,136
0.02% 141
2021
Q2
$221K Hold
2,136
0.02% 142
2021
Q1
$179K Hold
2,136
0.02% 137
2020
Q4
$194K Buy
2,136
+300
+16% +$24.9K 0.04% 130
2020
Q3
$146K Hold
1,836
0.03% 135
2020
Q2
$127K Hold
1,836
0.03% 133
2020
Q1
$115K Hold
1,836
0.03% 130
2019
Q4
$143K Hold
1,836
0.05% 123
2019
Q3
$135K Hold
1,836
0.07% 109
2019
Q2
$113K Hold
1,836
0.07% 110
2019
Q1
$117K Hold
1,836
0.06% 104
2018
Q4
$93K Hold
1,836
0.05% 105
2018
Q3
$107K Hold
1,836
0.06% 101
2018
Q2
$89K Sell
1,836
-1,020
-36% -$47.6K 0.05% 106
2018
Q1
$134K Buy
+2,856
New +$124K 0.08% 88

Other funds holding EW

Bogart Wealth LLC's EW Position: Q1 2026 in Review

Bogart Wealth LLC increased its Edwards Lifesciences (EW) stake by 36% in Q1 2026, buying an estimated $1.07K and bringing the position to 49 shares worth $3.92K. The position accounts for ﹤0.01% of the portfolio, ranked #1126.

Bogart Wealth LLC first reported a position in EW in Q1 2018 and has held it in 30 quarters since. The position peaked at $6.87M in Q4 2024. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Bogart Wealth LLC held 49 shares of Edwards Lifesciences worth $3.92K as of Q1 2026.
  • Bogart Wealth LLC bought 13 Edwards Lifesciences shares in Q1 2026, an estimated $1.07K.
  • Edwards Lifesciences made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q1 2026, its #1126 holding.
  • Bogart Wealth LLC first reported a position in Edwards Lifesciences in Q1 2018 and has held it in 30 quarters since.
  • Bogart Wealth LLC's Edwards Lifesciences position peaked at $6.87M in Q4 2024.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Bogart Wealth LLC's 13F filing for Q1 2026, filed 28 Apr 2026.